The University of Adelaide will introduce a suite of Allied Health degrees to its educational line-up in 2021.
An international clinical trial involving Adelaide researchers has demonstrated the safety and efficacy of a next-generation treatment for people with chronic myeloid leukaemia (CML).
The Adelaide China Biotech Investment Fund has today been launched – a new $45 million investment fund that will accelerate the development and commercialisation of health and bio-technologies from South Australia for the global market.
University of Adelaide led projects have received $9,401,459 to investigate a range of health issues such as how low-calorie sweeteners affect people with type 2 diabetes, using bioengineered tissue to rebuild eyes and the effectiveness of water fluoridation as a public health initiative.
New research shows that the more a baby weighs at birth relative to its gestational age the higher the risk they will suffer from childhood allergies.
A study into the impact of state-funded vaccination programs for Australian children under five years has found those attending medical practices in the wealthiest areas were more likely to receive the vaccine.
The University of Adelaide has experienced an increase in first-preference applications for its undergraduate degrees for 2020, with strong interest in STEM (science, technology, engineering and mathematics) programs.
Improving human health is the aim of $11.6 million in new research awarded to the University of Adelaide today, including a major project to investigate tackling two serious infections with one vaccine.